Rani-nerton en es it fr

Rani-nerton Brand names, Rani-nerton Analogs

Rani-nerton Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Rani-nerton Chemical_Formula


Rani-nerton RX_link


Rani-nerton fda sheet

Rani-nerton FDA

Rani-nerton msds (material safety sheet)

Rani-nerton MSDS

Rani-nerton Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Rani-nerton Molecular Weight

314.405 g/mol

Rani-nerton Melting Point

69-70 oC

Rani-nerton H2O Solubility

24.7 mg/mL

Rani-nerton State


Rani-nerton LogP


Rani-nerton Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Rani-nerton Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Rani-nerton Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Rani-nerton Absorption

Approximately 50% bioavailability orally.

Rani-nerton side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Rani-nerton Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Rani-nerton Organisms Affected

Humans and other mammals